View in EDS HTML Full Text PDF Full Text

Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers.

Saved in:
Bibliographic Details
Title: Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers.
Authors: Ackert J; Clinical Research and Development, GlaxoSmithKline, Collegeville, PA, USA., Mohamed K; Quantitative Sciences, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK., Slakter JS; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA., El-Harazi S; Lugene Eye Institute, Glendale, CA, USA., Berni A; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK., Gevorkyan H; California Clinical Trials Medical Group in affiliation with Parexel International, Glendale, CA, USA., Hardaker E; Safety Evaluation and Risk Management, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK., Hussaini A; PAREXEL, Harbor Hospital, Baltimore, Baltimore, MD, USA., Jones SW; Safety Evaluation and Risk Management, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK., Koh GCKW; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK., Patel J; Clinical Data Management, GlaxoSmithKline Research and Development, Collegeville, PA, USA., Rasmussen S; IQVIA, Overland Park, KS, USA., Kelly DS; Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Collegeville, PA, USA., Barañano DE; Retina Specialists, Baltimore, MD, USA., Thompson JT; Retina Specialists, Baltimore, MD, USA., Warren KA; IQVIA, Overland Park, KS, USA., Sergott RC; Neuro-Ophthalmology Service, Wills Eye Hospital, Philadelphia, PA, USA., Tonkyn J; GSK Medicines Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Wolstenholme A; GlaxoSmithKline, Upper Providence, Collegeville, PA, USA., Coleman H; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA., Yuan A; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA., Duparc S; Research and Development, Medicines for Malaria Venture, Geneva, Switzerland., Green JA; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK. justin.a.green@gsk.com.
Source: Drug safety [Drug Saf] 2019 Sep; Vol. 42 (9), pp. 1103-1114.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31187437
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ackert+J%22">Ackert J</searchLink>; Clinical Research and Development, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mohamed+K%22">Mohamed K</searchLink>; Quantitative Sciences, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK.<br /><searchLink fieldCode="AU" term="%22Slakter+JS%22">Slakter JS</searchLink>; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22El-Harazi+S%22">El-Harazi S</searchLink>; Lugene Eye Institute, Glendale, CA, USA.<br /><searchLink fieldCode="AU" term="%22Berni+A%22">Berni A</searchLink>; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK.<br /><searchLink fieldCode="AU" term="%22Gevorkyan+H%22">Gevorkyan H</searchLink>; California Clinical Trials Medical Group in affiliation with Parexel International, Glendale, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hardaker+E%22">Hardaker E</searchLink>; Safety Evaluation and Risk Management, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK.<br /><searchLink fieldCode="AU" term="%22Hussaini+A%22">Hussaini A</searchLink>; PAREXEL, Harbor Hospital, Baltimore, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Jones+SW%22">Jones SW</searchLink>; Safety Evaluation and Risk Management, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK.<br /><searchLink fieldCode="AU" term="%22Koh+GCKW%22">Koh GCKW</searchLink>; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK.<br /><searchLink fieldCode="AU" term="%22Patel+J%22">Patel J</searchLink>; Clinical Data Management, GlaxoSmithKline Research and Development, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Rasmussen+S%22">Rasmussen S</searchLink>; IQVIA, Overland Park, KS, USA.<br /><searchLink fieldCode="AU" term="%22Kelly+DS%22">Kelly DS</searchLink>; Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Barañano+DE%22">Barañano DE</searchLink>; Retina Specialists, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Thompson+JT%22">Thompson JT</searchLink>; Retina Specialists, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Warren+KA%22">Warren KA</searchLink>; IQVIA, Overland Park, KS, USA.<br /><searchLink fieldCode="AU" term="%22Sergott+RC%22">Sergott RC</searchLink>; Neuro-Ophthalmology Service, Wills Eye Hospital, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Tonkyn+J%22">Tonkyn J</searchLink>; GSK Medicines Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, UK.<br /><searchLink fieldCode="AU" term="%22Wolstenholme+A%22">Wolstenholme A</searchLink>; GlaxoSmithKline, Upper Providence, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Coleman+H%22">Coleman H</searchLink>; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Yuan+A%22">Yuan A</searchLink>; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Duparc+S%22">Duparc S</searchLink>; Research and Development, Medicines for Malaria Venture, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Green+JA%22">Green JA</searchLink>; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK. justin.a.green@gsk.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229002928%22">Drug safety</searchLink> [Drug Saf] 2019 Sep; Vol. 42 (9), pp. 1103-1114.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9002928 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201145916%22">01145916 </searchLink><i>NLM ISO Abbreviation: </i>Drug Saf <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31187437
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40264-019-00839-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1103
    Titles:
      – TitleFull: Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ackert J
      – PersonEntity:
          Name:
            NameFull: Mohamed K
      – PersonEntity:
          Name:
            NameFull: Slakter JS
      – PersonEntity:
          Name:
            NameFull: El-Harazi S
      – PersonEntity:
          Name:
            NameFull: Berni A
      – PersonEntity:
          Name:
            NameFull: Gevorkyan H
      – PersonEntity:
          Name:
            NameFull: Hardaker E
      – PersonEntity:
          Name:
            NameFull: Hussaini A
      – PersonEntity:
          Name:
            NameFull: Jones SW
      – PersonEntity:
          Name:
            NameFull: Koh GCKW
      – PersonEntity:
          Name:
            NameFull: Patel J
      – PersonEntity:
          Name:
            NameFull: Rasmussen S
      – PersonEntity:
          Name:
            NameFull: Kelly DS
      – PersonEntity:
          Name:
            NameFull: Barañano DE
      – PersonEntity:
          Name:
            NameFull: Thompson JT
      – PersonEntity:
          Name:
            NameFull: Warren KA
      – PersonEntity:
          Name:
            NameFull: Sergott RC
      – PersonEntity:
          Name:
            NameFull: Tonkyn J
      – PersonEntity:
          Name:
            NameFull: Wolstenholme A
      – PersonEntity:
          Name:
            NameFull: Coleman H
      – PersonEntity:
          Name:
            NameFull: Yuan A
      – PersonEntity:
          Name:
            NameFull: Duparc S
      – PersonEntity:
          Name:
            NameFull: Green JA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2019 Sep
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1942
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Drug safety
              Type: main
ResultId 1